Concordia (CXRX) Says CMA is Investigating New Issues for UK Pharmaceutical Sector and its Segment and Certain of its Products are Part of Inquiry

October 11, 2017 7:08 AM EDT Send to a Friend
Concordia International Corp. (NASDAQ: CXRX) today announced that the UK Competition and Markets Authority (CMA) is investigating new issues ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login